Robert K. Stuart

15.5k total citations · 3 hit papers
198 papers, 6.9k citations indexed

About

Robert K. Stuart is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Robert K. Stuart has authored 198 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 65 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Robert K. Stuart's work include Acute Myeloid Leukemia Research (64 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Multiple Myeloma Research and Treatments (23 papers). Robert K. Stuart is often cited by papers focused on Acute Myeloid Leukemia Research (64 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Multiple Myeloma Research and Treatments (23 papers). Robert K. Stuart collaborates with scholars based in United States, United Kingdom and Canada. Robert K. Stuart's co-authors include Rein Saral, George W. Santos, Herbert Kaizer, Lyle L. Sensenbrenner, Harry P. Erba, William H. Burns, Hayden G. Braine, Andrew M. Yeager, Luciano J. Costa and Scott D. Rowley and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert K. Stuart

193 papers receiving 6.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1983 621 citations George W. Santos, Robert K. Stuart et al. profile →
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

2014 595 citations Robert K. Stuart et al. Blood profile →
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

2013 460 citations Robert K. Stuart et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert K. Stuart	3.4k	2.0k	2.0k	931	917	198	6.9k
Jayesh Mehta	4.9k 1.4×	2.8k 1.4×	2.7k 1.4×	1.1k 1.1×	1.0k 1.1×	226	8.3k
Roy B. Jones	3.4k 1.0×	2.5k 1.2×	970 0.5×	791 0.8×	1.2k 1.3×	176	6.6k
Shinichiro Okamoto	3.3k 1.0×	1.5k 0.7×	1.1k 0.5×	1.1k 1.2×	1.3k 1.4×	389	7.1k
R Powles	4.1k 1.2×	2.2k 1.1×	1.4k 0.7×	1.2k 1.3×	779 0.8×	194	6.2k
Graham Jackson	5.0k 1.4×	3.1k 1.5×	3.5k 1.7×	1.6k 1.7×	786 0.9×	221	7.9k
Thomas C. Shea	1.8k 0.5×	2.5k 1.3×	1.6k 0.8×	576 0.6×	618 0.7×	172	5.6k
David D. Hurd	2.4k 0.7×	1.6k 0.8×	1.2k 0.6×	494 0.5×	808 0.9×	159	4.8k
Martin F. Fey	2.1k 0.6×	3.0k 1.5×	3.1k 1.6×	1.0k 1.1×	927 1.0×	189	8.0k
Adrian C. Newland	3.9k 1.1×	1.2k 0.6×	1.8k 0.9×	1.6k 1.8×	1.2k 1.3×	281	8.1k
Ulrich Jäger	2.4k 0.7×	1.7k 0.8×	1.8k 0.9×	1.2k 1.2×	1.2k 1.3×	172	5.7k

Countries citing papers authored by Robert K. Stuart

Since Specialization

Citations

This map shows the geographic impact of Robert K. Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Stuart more than expected).

Fields of papers citing papers by Robert K. Stuart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Stuart. The network helps show where Robert K. Stuart may publish in the future.

Co-authorship network of co-authors of Robert K. Stuart

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. Stuart. A scholar is included among the top collaborators of Robert K. Stuart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. Stuart. Robert K. Stuart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ouyang, Zhengxiao, Thomas Cosker, Robert K. Stuart, et al.. (2023). The incidence, risk factors and outcomes of wound complications after preoperative radiotherapy and surgery for high grade extremity soft tissue sarcomas: A 14-year retrospective study. European Journal of Surgical Oncology. 49(11). 107086–107086. 4 indexed citations

Chari, Ajai, Saulius Girnius, Saurabh Chhabra, et al.. (2017). Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 130. 3111–3111. 2 indexed citations

Jensen, Dennis M., Stefan Eklund, Tore Persson, et al.. (2017). Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial. The American Journal of Gastroenterology. 112(3). 441–446. 39 indexed citations

God, Jason M., Christine Cameron, Azim Hossain, et al.. (2015). Elevation of c-MYC Disrupts HLA Class II–Mediated Immune Recognition of Human B Cell Tumors. The Journal of Immunology. 194(4). 1434–1445. 42 indexed citations

Cripe, Larry D., Glenn Michelson, Judith A. Fox, et al.. (2014). A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia. Haematologica. 100(2). 231–237. 24 indexed citations

Stuart, Robert K., et al.. (2012). Vosaroxin: a novel antineoplastic quinolone. Expert Opinion on Investigational Drugs. 21(8). 1223–1233. 33 indexed citations

Wolff, Daynna J., et al.. (2012). Association of age with fluorescencein situhybridization abnormalities in multiple myeloma reveals higher rate ofIGHtranslocations among older patients. Leukemia & lymphoma. 53(12). 2444–2448. 4 indexed citations

Costa, Luciano J., et al.. (2010). Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization. Bone Marrow Transplantation. 46(1). 64–69. 101 indexed citations

Miller, Ashley, et al.. (2010). Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus–Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 17(8). 1176–1181. 55 indexed citations

10.

Day, Terry A., M. Boyd Gillespie, Bonnie Martin‐Harris, et al.. (2008). Proximal Esophageal Stenosis in Head and Neck Cancer Patients after Total Laryngectomy and Radiation. ORL. 70(4). 229–235. 29 indexed citations

11.

Koch, David, et al.. (2007). Posttransplantation Lymphoproliferative Disorder—the Great Mimic in Liver Transplantation. Liver Transplantation. 13(6). 904–912. 30 indexed citations

12.

Day, Terry A., John P. Deveikis, M. Boyd Gillespie, et al.. (2004). Salivary gland neoplasms. Current Treatment Options in Oncology. 5(1). 11–26. 35 indexed citations

13.

Onitilo, Adedayo A., et al.. (2003). Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplantation Proceedings. 35(8). 3089–3092. 8 indexed citations

14.

Ezzat, Adnan, Ezzeldin M. Ibrahim, Dahish Ajarim, et al.. (2000). High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast Cancer Research and Treatment. 62(3). 237–244. 19 indexed citations

15.

Ezzat, Adnan, et al.. (1999). Malignant Ovarian Germ Cell Tumours: A Survival and Prognostic Analysis. Acta Oncologica. 38(4). 455–460. 18 indexed citations

16.

Ibrahim, Ezzeldin M., Fatma A. Al-Mulhim, Ali Al Bshabshe, et al.. (1998). Breast cancer in the eastern province of Saudi Arabia. Medical Oncology. 15(4). 241–247. 39 indexed citations

17.

Poynton, Ashley R., T. N. Walsh, Alan Kelly, et al.. (1997). Small cell carcinoma of the oesophagus. European Journal of Surgical Oncology. 23(6). 509–512. 13 indexed citations

18.

Colvin, O. Michael, et al.. (1989). In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging. Cancer Chemotherapy and Pharmacology. 23(3). 129–34. 7 indexed citations

19.

Spivak, Jerry L., Beth B. Murinson, & Robert K. Stuart. (1989). Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells.. Journal of Clinical Investigation. 83(1). 100–107. 7 indexed citations

20.

Szeluga, Debra J., Robert K. Stuart, Virginia Utermohlen, & George W. Santos. (1984). Nutritional assessment by isotope dilution analysis of body composition. American Journal of Clinical Nutrition. 40(4). 847–854. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact